With the healthcare landscape continually evolving, the generic medicines industry guarantees widespread access to affordable medications for millions of patients worldwide. Generics play a pivotal ...

Teva Pharmaceutical Industries Limited has successfully shifted its strategy, leveraging its generics business to fund growth in specialty medicines, driving a turnaround in performance. TEVA's "Pivot ...

President Trump said he expects to reach pricing deals with more drug companies following the Pfizer announcement. Photo: Win McNamee/Getty Images WASHINGTON—The Trump administration said it isn’t ...

Generics Awareness Month took center stage at the Mercury Drug Q-Plaza Branch in Cainta recently, where RHEA Generics, in support of the Department of Health (DOH) and in partnership with Mercury Drug ...

This latest FDA program aims to provide speedier reviews for generic drugmakers who produce their products in the U.S. Keeping up its string of pilots in recent months, the FDA on Friday unwrapped a ...

Shares in AbbVie were climbing today after the company revealed that it has settled litigation with generic drugmakers and should prevent generic competition for its big-selling Rinvoq brand in the US ...

ANDERLECHT, Belgium--(BUSINESS WIRE)--A.forall is pleased to announce the acquisition of four FDA-approved injectable generics and two late-stage pipeline assets from Provepharm's US portfolio. With ...

Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. America’s generic drug market is one of our greatest health ...

As the global pharmaceutical landscape undergoes rapid change with advances in novel drug discovery, smarter manufacturing, and shifting trade policies, India is uniquely positioned to lead this ...

The global branded generics market is forecasted to expand from USD 382.4 billion in 2025 to USD 860.5 billion by 2035, registering a CAGR of 8.4%. This growth is driven by rising healthcare ...

Generic medicines form the backbone of treatment accessibility across Europe, yet their impact extends far beyond simply being cheaper alternatives to brand-name drugs. These medications account for a ...